Literature DB >> 12116346

Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens.

M Bergeron1, J K A Nicholson, S Phaneuf, T Ding, N Soucy, A D Badley, N C Hawley Foss, F Mandy.   

Abstract

BACKGROUND: In the past decade, human immunodeficiency virus (HIV) lymphocyte immunophenotyping has evolved significantly. New fluorochromes, new multicolor reagents, enhanced instruments, and the capacity to provide absolute cell counts using the single-platform technique have all contributed to the reliability of T-cell subset measurements. In this study, four gating protocols were evaluated to select the most robust method for T-cell subset enumeration.
METHODS: Peripheral blood specimens from 21 HIV(+) and 20 HIV(-) individuals were monitored up to 96 h. Aliquots of specimens were stored at room temperature and analyzed at 6 (baseline), 48, 72, and 96 h. Aliquots were stained with CD45-fluorescein isothiocyanate (FITC)/CD3PC5/CD4RD1/CD8ECD. Data analysis was performed with all four gating protocols.
RESULTS: Only with fresh blood did all protocols provide similar results. From samples that were 48 h old, the choice of gating strategy had a dramatic impact on immunophenotyping results. The largest deviations from baseline values occurred at 96 h and gating protocols that included dual light scatter gates provided the greatest shift of T-cell subset values over time. The gating protocols that were based exclusively on cell lineage-specific gates gave the most robust T-cell values up to 96 h.
CONCLUSION: By selecting the appropriate gating protocol, the temporal integrity of specimens can be extended up to 4 days. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116346     DOI: 10.1002/cyto.10092

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  8 in total

1.  Affordable CD4(+)-T-cell counting by flow cytometry: CD45 gating for volumetric analysis.

Authors:  George Janossy; Ilesh V Jani; Nicholas J Bradley; Arsene Bikoue; Tim Pitfield; Debbie K Glencross
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

2.  Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters.

Authors:  Cécile Gouttefangeas; Cliburn Chan; Sebastian Attig; Tania T Køllgaard; Hans-Georg Rammensee; Stefan Stevanović; Dorothee Wernet; Per thor Straten; Marij J P Welters; Christian Ottensmeier; Sjoerd H van der Burg; Cedrik M Britten
Journal:  Cancer Immunol Immunother       Date:  2015-02-18       Impact factor: 6.968

3.  A potent sphingomyelinase inhibitor from Cordyceps mycelia contributes its cytoprotective effect against oxidative stress in macrophages.

Authors:  Shwu-Huey Wang; Wen-Bin Yang; Yin-Chen Liu; Yi-Hua Chiu; Chien-Tsu Chen; Pai-Feng Kao; Chun-Mao Lin
Journal:  J Lipid Res       Date:  2011-01-07       Impact factor: 5.922

4.  Time and temperature stability of T-cell subsets evaluated by a dual-platform method.

Authors:  Horatiu Olteanu; Bernard C Schur; Alexandra M Harrington; Steven H Kroft
Journal:  Am J Blood Res       Date:  2012-05-25

Review 5.  CD4 immunophenotyping in HIV infection.

Authors:  David Barnett; Brooke Walker; Alan Landay; Thomas N Denny
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

Review 6.  Cytokines and other immunological biomarkers in children's environmental health studies.

Authors:  Paurene Duramad; Ira B Tager; Nina T Holland
Journal:  Toxicol Lett       Date:  2007-05-25       Impact factor: 4.372

Review 7.  Current practices in laboratory monitoring of HIV infection.

Authors:  Madhu Vajpayee; Teena Mohan
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

8.  Performance of the PointCare NOW system for CD4 counting in HIV patients based on five independent evaluations.

Authors:  Michèle Bergeron; Géraldine Daneau; Tao Ding; Nadia E Sitoe; Larry E Westerman; Jocelijn Stokx; Ilesh V Jani; Lindi M Coetzee; Lesley Scott; Anja De Weggheleire; Luc Boel; Wendy S Stevens; Deborah K Glencross; Trevor F Peter
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.